Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
The U.S. Food & Drug Administration releases a list of pre-market approvals granted in February 2014. Read more
Illinois healthcare titan Abbott closed enrollment in 3 clinical trials after treating about 2,800 patients with the company’s dissolving Absorb drug-eluting scaffold.
The studies included about 2,000 patients in the U.S. and 400 patients each in trials in China and Japan, according to a company statement. Abbott is pursuing regulatory approvals in all 3 regions, which together represent 50% of the world’s heart stent market. Read more
Senator Joe Donnelly (D-Ind.) is hoping to garner the support of new Senate Finance Committee Chairman Ron Wyden (D-Ore.) in efforts to repeal the medical device tax.
In an open letter issued yesterday, Donnelly congratulated Wyden on his new role and voiced concerns that the medtech tax is hurting American innovation. Read more